Genomic
Health, Inc
|
||||
(Name
of Issuer)
|
||||
Common
Stock, par value $0.0001 per share
|
||||
(Title
of Class of Securities)
|
||||
37244C101
|
||||
(CUSIP
Number)
|
||||
Leo
Kirby
667
Madison Avenue, 17th Floor
New
York, NY 10065
(212)
339-5633
|
||||
(Name,
Address and Telephone Number of Person Authorized to Receive Notices and
Communications)
|
||||
August
13, 2009
|
||||
(Date
of Event which Requires Filing of this Statement)
|
||||
CUSIP
No. 37244C101
|
Page
2 of 8
Pages
|
1
|
NAMES
OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE
PERSONS
Julian C.
Baker
|
||||
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See
Instructions)
|
(a)
o
(b)
o
|
|||
3
|
SEC
USE ONLY
|
||||
4
|
SOURCE
OF FUNDS (See Instructions)
WC
|
||||
5
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d)
OR 2(e)
|
o
|
|||
6
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United
States
|
||||
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE
VOTING POWER
24,750
|
|||
8
|
SHARED
VOTING POWER
5,746,322
|
||||
9
|
SOLE
DISPOSITIVE POWER
24,750
|
||||
10
|
SHARED
DISPOSITIVE POWER
5,746,322
|
||||
11
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,771,072
|
||||
12
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See
Instructions)
|
o
|
|||
13
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
20.2%
|
||||
14
|
TYPE
OF REPORTING PERSON (See Instructions)
IN
|
CUSIP
No. 37244C101
|
Page
3 of 8
Pages
|
1
|
NAMES
OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE
PERSONS
Felix J. Baker
|
||||
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See
Instructions)
|
(a) o
(b) o
|
|||
3
|
SEC
USE ONLY
|
||||
4
|
SOURCE
OF FUNDS (See Instructions)
WC
|
||||
5
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d)
OR 2(e)
|
o
|
|||
6
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United
States
|
||||
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE
VOTING POWER
0
|
|||
8
|
SHARED
VOTING POWER
5,746,322
|
||||
9
|
SOLE
DISPOSITIVE POWER
0
|
||||
10
|
SHARED
DISPOSITIVE POWER
5,746,322
|
||||
11
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,746,322
|
||||
12
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See
Instructions)
|
o
|
|||
13
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
20.1%
|
||||
14
|
TYPE
OF REPORTING PERSON (See Instructions)
IN
|
Item
5.
|
Interest
in Securities of the Issuer.
|
Name
|
Number
of Shares
|
Percent
of Class
Outstanding
|
||||||
Baker
Bros. Investments, L.P.
|
173,897 | 0.6 | % | |||||
Baker
Bros. Investments II, L.P.
|
20,287 | 0.1 | % | |||||
667,
L.P.
|
1,253,653 | 4.4 | % | |||||
Baker
Brothers Life Sciences, L.P.
|
3,826,820 | 13.4 | % | |||||
14159,
L.P.
|
103,607 | 0.3 | % | |||||
FBB
Associates
|
173,897 | 0.6 | % | |||||
Baker/Tisch
Investments, L.P.
|
194,161 | 0.7 | % | |||||
Julian
C. Baker
|
24,750 | 0.1 | % | |||||
|
||||||||
Total
|
5,771,072 | 20.2 | % |
Name
|
Date
|
Number
of
|
||||||||
Shares
|
Transaction
|
Price
/ Share
|
||||||||
Baker
Bros. Investments II, L.P.
|
8/10/2009
|
6 |
Purchase
|
19.4996 | ||||||
667,
L.P.
|
8/10/2009
|
2,208 |
Purchase
|
19.4996 | ||||||
Baker
Brothers Life Sciences, L.P.
|
8/10/2009
|
12,622 |
Purchase
|
19.4996 | ||||||
14159,
L.P.
|
8/10/2009
|
349 |
Purchase
|
19.4996 | ||||||
Baker
Bros. Investments II, L.P.
|
8/10/2009
|
4 |
Purchase
|
19.4793 | ||||||
667,
L.P.
|
8/10/2009
|
1,454 |
Purchase
|
19.4793 | ||||||
Baker
Brothers Life Sciences, L.P.
|
8/10/2009
|
8,312 |
Purchase
|
19.4793 | ||||||
14159,
L.P.
|
8/10/2009
|
230 |
Purchase
|
19.4793 | ||||||
Baker
Bros. Investments II, L.P.
|
8/11/2009
|
16 |
Purchase
|
19.3657 | ||||||
667,
L.P.
|
8/11/2009
|
5,623 |
Purchase
|
19.3657 | ||||||
Baker
Brothers Life Sciences, L.P.
|
8/11/2009
|
32,139 |
Purchase
|
19.3657 | ||||||
14159,
L.P.
|
8/11/2009
|
888 |
Purchase
|
19.3657 | ||||||
667,
L.P.
|
8/11/2009
|
44 |
Purchase
|
19.4700 | ||||||
Baker
Brothers Life Sciences, L.P.
|
8/11/2009
|
249 |
Purchase
|
19.4700 | ||||||
14159,
L.P.
|
8/11/2009
|
7 |
Purchase
|
19.4700 | ||||||
Baker
Bros. Investments II, L.P.
|
8/11/2009
|
5 |
Purchase
|
19.3585 | ||||||
667,
L.P.
|
8/11/2009
|
1,858, |
Purchase
|
19.3585 | ||||||
Baker
Brothers Life Sciences, L.P.
|
8/11/2009
|
10,624 |
Purchase
|
19.3585 | ||||||
14159,
L.P.
|
8/11/2009
|
294 |
Purchase
|
19.3585 | ||||||
Baker
Bros. Investments II, L.P.
|
8/12/2009
|
14 |
Purchase
|
19.6969 | ||||||
667,
L.P.
|
8/12/2009
|
4,690 |
Purchase
|
19.6969 | ||||||
Baker
Brothers Life Sciences, L.P.
|
8/12/2009
|
26,808 |
Purchase
|
19.6969 | ||||||
14159,
L.P.
|
8/12/2009
|
740 |
Purchase
|
19.6969 | ||||||
Baker
Bros. Investments II, L.P.
|
8/13/2009
|
33 |
Purchase
|
19.9896 | ||||||
667,
L.P.
|
8/13/2009
|
11,314 |
Purchase
|
19.9896 | ||||||
Baker
Brothers Life Sciences, L.P.
|
8/13/2009
|
64,668 |
Purchase
|
19.9896 | ||||||
14159,
L.P.
|
8/13/2009
|
1,785 |
Purchase
|
19.9896 | ||||||
Baker
Bros. Investments II, L.P.
|
8/17/2009
|
1 |
Purchase
|
19.6000 | ||||||
667,
L.P.
|
8/17/2009
|
343 |
Purchase
|
19.6000 | ||||||
Baker
Brothers Life Sciences, L.P.
|
8/17/2009
|
1,962 |
Purchase
|
19.6000 | ||||||
14159,
L.P.
|
8/17/2009
|
54 |
Purchase
|
19.6000 |
Item
7.
|
Material
to Be Filed as Exhibits.
|
Exhibit
1.
|
Agreement
regarding the joint filing of this
statement.
|
August
17, 2009
|
By:
|
/s/ Julian C. Baker | |
Julian
C. Baker
|
|||
By:
|
/s/
Felix J. Baker
|
||
Felix J. Baker |
August
17, 2009
|
By:
|
/s/
Julian C. Baker
|
|
Julian
C. Baker
|
|||
By:
|
/s/
Felix J. Baker
|
||
Felix
J. Baker
|